Advertisement

Effects of High Residential Segregation and Neighborhood Characteristics on Early-Stage NSCLC Surgery

Advertisement

Key Points

  • For black patients, the level of segregation of their neighborhoods was the strongest predictor of whether they would receive the surgery.
  • For white patients, educational levels in the neighborhood played the largest role in determining their chances of receiving the surgery.
  • Black patients living in the neighborhoods with the highest levels of segregation and economic deprivation were 31% more likely to die than black patients living in the least segregated and economically deprived areas.

Black residents of highly segregated neighborhoods were less likely to receive surgery for early-stage non–small cell lung cancer (NSCLC) than their peers in less-segregated neighborhoods, according to a study published by Johnson et al in Cancer Epidemiology, Biomarkers & Prevention.

“It has been established that black patients have higher cancer mortality rates and are less likely to receive appropriate treatment than whites,” said the study’s lead author, Asal Mohamadi Johnson, PhD, MPH, Assistant Professor of Integrative Health Science at Stetson University. “Instead of solely looking at health disparities between white and black patients, our study focused on differences in survival among black patients resulting from different levels of neighborhood segregation.”

Dr. Johnson’s study focused on NSCLC, the most common type of lung cancer. If caught at an early stage, the disease can sometimes be cured by surgical resection. Previous research has documented disparities in the rate of receipt of NSCLC surgery and in survival. 

“At least half of patients diagnosed at early stages who undergo surgical treatment survive more than 5 years, whereas, without surgery, most will die within 1 year,” Dr. Johnson said.

Study Findings

For this study, Dr. Johnson and colleagues conducted a retrospective cohort study of patients diagnosed with NSCLC between January 2000 and December 2009, using data from the Georgia Comprehensive Cancer Registry. Researchers measured the degree of segregation of the patients’ neighborhoods by isolation index, which measures the probability of living in proximity to individuals from the same racial or ethnic group. They used economic deprivation as a second variable, and because segregation and economic deprivation are often linked, researchers created a third variable combining the two. The researchers also considered educational attainment.

For black patients, the level of segregation of their neighborhoods was the strongest predictor of whether they would receive the surgery. The study showed that compared with patients living in the least-segregated areas, the patients in the most-segregated areas were 65% less likely to receive the surgery. The patients in the second most-segregated areas were 63% less likely to receive the surgery.

For white patients, educational levels in the neighborhood played the largest role in determining their chances of receiving the surgery. The white patients who lived in areas with the lowest levels of education were 48% less likely to receive the surgery compared with those living in areas with the most highly educated population. Segregation had no significant effect.

Black patients also had a lower 5-year survival compared with white patients. However, after controlling for receipt of surgery, the survival disparity between black and white patients disappeared, suggesting this disparity may be largely explained by differences in receipt of surgery. Black patients living in the neighborhoods with the highest levels of segregation and economic deprivation were 31% more likely to die than black patients living in the least segregated and economically deprived areas.

Dr. Johnson said a limitation of the study is that researchers did not have data on individual socioeconomic status, comorbidity, and specific causes of death. Also, she said, segregation can be measured in numerous ways, and alternate measures may have resulted in different results.

The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.


Advertisement

Advertisement




Advertisement